All Stories

  1. Anti-inflammatory and antiproliferative activity of Helichrysum odoratissimum Sweet. against lung cancer
  2. Assessing the gene silencing potential of AuNP-based approaches on conventional 2D cell culture versus 3D tumor spheroid
  3. Doxorubicin-sensitive and -resistant colorectal cancer spheroid models: assessing tumor microenvironment features for therapeutic modulation
  4. Tackling Imatinib Resistance via Au‐nanoconjugates using A Cml Resistant Cell Line
  5. Half-sandwich Ru(II) N-heterocyclic carbene complexes in anticancer drug design
  6. Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells
  7. In Vitro and In Vivo Biological Activities of Dipicolinate Oxovanadium(IV) Complexes
  8. Hybrid Digital-Droplet Microfluidic Chip for Applications in Droplet Digital Nucleic Acid Amplification: Design, Fabrication and Characterization
  9. Parylene C as a Multipurpose Material for Electronics and Microfluidics
  10. Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples
  11. Exploring RAB11A Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo
  12. Cell Uptake of Steroid-BODIPY Conjugates and Their Internalization Mechanisms: Cancer Theranostic Dyes
  13. Open-source tool for real-time and automated analysis of droplet-based microfluidic
  14. Short Lecture 4 “Evaluation of antiproliferative and anti-angiogenic activity of an ethanolic extract of Helichrysum odoratissimum (L.) Sweet against skin cancer”
  15. Antiproliferative Activity of Buddleja saligna (Willd.) against Melanoma and In Vivo Modulation of Angiogenesis
  16. In Vitro and In Vivo Biological Activity of Ruthenium 1,10-Phenanthroline-5,6-dione Arene Complexes
  17. Editorial: Rational drug design of metal complexes for cancer therapy
  18. Engineering gold nanoparticles for molecular diagnostics and biosensing
  19. Digital Microfluidics for Amplification Monitoring of Cancer Biomarkers
  20. Digital Microfluidics-Powered Real-Time Monitoring of Isothermal DNA Amplification of Cancer Biomarker
  21. Endogenous Fluorescent Proteins in the Mucus of an Intertidal Polychaeta: Clues for Biotechnology
  22. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer
  23. Light Triggered Enhancement of Antibiotic Efficacy in Biofilm Elimination Mediated by Gold-Silver Alloy Nanoparticles
  24. A solvent‐free strategy to prepare amorphous salts of folic acid with enhanced solubility and cell permeability
  25. Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
  26. Boron clusters (ferrabisdicarbollides) shaping the future as radiosensitizers for multimodal (chemo/radio/PBFR) therapy of glioblastoma
  27. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
  28. Aggregation versus Biological Activity in Gold(I) Complexes. An Unexplored Concept
  29. New Non-Toxic N-alkyl Cholinium-Based Ionic Liquids as Excipients to Improve the Solubility of Poorly Water-Soluble Drugs
  30. Manganese(I) tricarbonyl complexes as potential anticancer agents
  31. Vanadium(IV) Complexes with Methyl-Substituted 8-Hydroxyquinolines: Catalytic Potential in the Oxidation of Hydrocarbons and Alcohols with Peroxides and Biological Activity
  32. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2′:6′,2″-terpyridine ligands: From in vitro to in vivo biological properties
  33. Inflammatory factors, genetic variants , and predisposition for preterm birth
  34. Genetic predisposition for aggressive behaviour related with dopamine and serotonin pathways – an overview
  35. The genetic susceptibility linking preterm birth and periodontal disease – a review
  36. Liposomal Nanosystems in Rheumatoid Arthritis
  37. Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury
  38. In Vitro and In Vivo Effect of Palladacycles: Targeting A2780 Ovarian Carcinoma Cells and Modulation of Angiogenesis
  39. Rosa x hybrida extracts with dual actions: Antiproliferative effects against tumour cells and inhibitor of Alzheimer disease
  40. Combined cancer therapeutics—Tackling the complexity of the tumor microenvironment
  41. A Transcriptomic Approach to the Recruitment of Venom Proteins in a Marine Annelid
  42. Specific Antiproliferative Properties of Proteinaceous Toxin Secretions from the Marine Annelid Eulalia sp. onto Ovarian Cancer Cells
  43. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line
  44. Cu(i) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action
  45. Benchtop X-ray fluorescence imaging as a tool to study gold nanoparticle penetration in 3D cancer spheroids
  46. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities
  47. Water safety screening via multiplex LAMP-Au-nanoprobe integrated approach
  48. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  49. Hyperthermia Induced by Gold Nanoparticles and Visible Light Photothermy Combined with Chemotherapy to Tackle Doxorubicin Sensitive and Resistant Colorectal Tumor 3D Spheroids
  50. Tackling Multidrug Resistance in Streptococci – From Novel Biotherapeutic Strategies to Nanomedicines
  51. The Intracellular Number of Magnetic Nanoparticles Modulates the Apoptotic Death Pathway after Magnetic Hyperthermia Treatment
  52. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
  53. Nanotheranostics in Gene Therapy
  54. Synthesis of new hetero-arylidene-9(10H)-anthrone derivatives and their biological evaluation
  55. Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol
  56. Fast Prototyping Microfluidics: Integrating Droplet Digital Lamp for Absolute Quantification of Cancer Biomarkers
  57. Gene Therapy in Cancer Treatment: Why Go Nano?
  58. Size-Dependent Biological Activities of Fluorescent Organosilane-Modified Zinc Oxide Nanoparticles
  59. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes
  60. Improving the Anti-inflammatory Response via Gold Nanoparticle Vectorization of CO-Releasing Molecules
  61. RNA Quantification Using Noble Metal Nanoprobes: Simultaneous Identification of Several Different mRNA Targets Using Color Multiplexing and Application to Chronic Myeloid Leukemia Diagnostics
  62. Paper-Based SERS Platform for One-Step Screening of Tetracycline in Milk
  63. Light Irradiation of Gold Nanoparticles Toward Advanced Cancer Therapeutics
  64. Cation-mediated gelation of the fucose-rich polysaccharide FucoPol: preparation and characterization of hydrogel beads and their cytotoxicity assessment
  65. Targeting Cancer Resistance via Multifunctional Gold Nanoparticles
  66. Antiproliferative activity of heterometallic sodium and potassium-dioxidovanadium(V) polymers
  67. Structural characterization and biological properties of silver(I) tris(pyrazolyl)methane sulfonate
  68. Nanotheranostics Targeting the Tumor Microenvironment
  69. Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles
  70. Occurrence of non-toxic bioemulsifiers during polyhydroxyalkanoate production by Pseudomonas strains valorizing crude glycerol by-product
  71. Ionic Liquids and Salts from Ibuprofen as Promising Innovative Formulations of an Old Drug
  72. Structural aspects of a trimetallic CuII derivative: cytotoxicity and anti-proliferative activity on human cancer cell lines
  73. Enhancement of water solubility of poorly water-soluble drugs by new biocompatible N-acetyl amino acid N-alkyl cholinium-based ionic liquids
  74. New lessons from ancient life: marine invertebrates as a source of new drugs
  75. Targeting Tumor Microenvironment for Cancer Therapy
  76. GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach
  77. Antibody modified gold nanoparticles for fast colorimetric screening of rheumatoid arthritis
  78. A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
  79. Front Cover: The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes (Chem. Eur. J. 55/2018)
  80. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  81. The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes
  82. Cover Feature: POxylated Dendrimer-Based Nano-in-Micro Dry Powder Formulations for Inhalation Chemotherapy (ChemistryOpen 10/2018)
  83. A double Philadelphia chromosome-positive chronic myeloid leukemia patient, co-expressing P210BCR-ABL1 and P195BCR-ABL1 isoforms
  84. Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells
  85. Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics: an update
  86. POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
  87. Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
  88. Evaluation of cell toxicity and DNA and protein binding of green synthesized silver nanoparticles
  89. Optical and Structural Characterization of a Chronic Myeloid Leukemia DNA Biosensor
  90. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells
  91. Synthesis, Cytotoxicity Evaluation in Human Cell Lines and in Vitro DNA Interaction of a Hetero‐Arylidene‐9(10H)‐Anthrone
  92. Multifunctional microfluidic chip for optical nanoprobe based RNA detection – application to Chronic Myeloid Leukemia
  93. Nanoparticles—Emerging Potential for Managing Leukemia and Lymphoma
  94. Allele specific LAMP- gold nanoparticle for characterization of single nucleotide polymorphisms
  95. Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalised gold nanoparticles
  96. A Digital Microfluidics Platform for Loop-Mediated Isothermal Amplification Detection
  97. Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles
  98. Digital Microfluidics for Nucleic Acid Amplification
  99. Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia
  100. Quantitative real-time monitoring of RCA amplification of cancer biomarkers mediated by a flexible ion sensitive platform
  101. Smuggling gold nanoparticles across cell types – A new role for exosomes in gene silencing
  102. Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer—The Case for Combined Delivery?
  103. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds
  104. Tumor Microenvironment Modulation via Gold Nanoparticles Targeting Malicious Exosomes: Implications for Cancer Diagnostics and Therapy
  105. Gold Nanobeacons for Tracking Gene Silencing in Zebrafish
  106. Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents
  107. Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy
  108. Gold Nanoparticles in Molecular Diagnostics and Molecular Therapeutics
  109. Current trends in molecular diagnostics of chronic myeloid leukemia
  110. Gold Nanoparticles for Diagnostics: Advances towards Points of Care
  111. Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo
  112. Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
  113. BioCode gold-nanobeacon for the detection of fusion transcripts causing chronic myeloid leukemia
  114. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT
  115. Infection of human keratinocytes by Streptococcus dysgalactiae subspecies dysgalactiae isolated from milk of the bovine udder
  116. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy
  117. Synthesis, characterization, thermal properties and antiproliferative potential of copper(ii) 4′-phenyl-terpyridine compounds
  118. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
  119. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos
  120. A novel mutation inCEBPAgene in a patient with acute myeloid leukemia
  121. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
  122. Scalable approach for the production of functional DNA based gold nanoprobes
  123. Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
  124. Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles
  125. Gold nanoprobe-based non-crosslinking hybridization for molecular diagnostics
  126. One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care
  127. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects
  128. 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  129. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine
  130. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
  131. Field Effect Sensors for Nucleic Acid Detection: Recent Advances and Future Perspectives
  132. Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial
  133. Nanoparticles for Diagnostics and Imaging
  134. DNA adduct identification using gold-aptamer nanoprobes
  135. Single nucleotide polymorphism detection using gold nanoprobes and bio-microfluidic platform with embedded microlenses
  136. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing
  137. Mobile Based Gold Nanoprobe TB Diagnostics for Point-of-Need
  138. Characterization of genomic single nucleotide polymorphism via colorimetric detection using a single gold nanoprobe
  139. Metabolic and histopathological alterations in the marine bivalve Mytilus galloprovincialis induced by chronic exposure to acrylamide
  140. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles
  141. Gold nanobeacons: a potential nanotheranostics platform
  142. A promising road with challenges: where are gold nanoparticles in translational research?
  143. Cancer therapy
  144. AuNPs for identification of molecular signatures of resistance
  145. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
  146. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
  147. Dual-color control of nucleotide polymerization sensed by a fluorescence actuator
  148. Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis
  149. A low cost, safe, disposable, rapid and self-sustainable paper-based platform for diagnostic testing: lab-on-paper
  150. Ion sensing (EIS) real-time quantitative monitorization of isothermal DNA amplification
  151. Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies
  152. Star-shaped magnetite@gold nanoparticles for protein magnetic separation and SERS detection
  153. Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells
  154. Histopathological findings onCarassius auratushepatopancreas upon exposure to acrylamide: correlation with genotoxicity and metabolic alterations
  155. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models
  156. Coupling an universal primer to SBE combined spectral codification strategy for single nucleotide polymorphism analysis
  157. Bio-microfluidic platform for gold nanoprobe based DNA detection—application to Mycobacterium tuberculosis
  158. THE CHEMISTRY AND BIOLOGY OF GOLD NANOPARTICLE-MEDIATED PHOTOTHERMAL THERAPY: PROMISES AND CHALLENGES
  159. Association of FTO and PPARG polymorphisms with obesity in Portuguese women
  160. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
  161. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events
  162. Fast nucleotide identification through fingerprinting using gold nanoparticle-based surface-assisted laser desorption/ionisation
  163. Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
  164. Isothermal DNA amplification coupled to Au-nanoprobes for detection of mutations associated to Rifampicin resistance in Mycobacterium tuberculosis
  165. Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles
  166. Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
  167. Could gold nanoprobes be an important tool in cancer diagnostics?
  168. Gold-nanobeacons for real-time monitoring of RNA synthesis
  169. Gold and silver nanoparticles for clinical diagnostics — From genomics to proteomics
  170. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles
  171. Enhancement of antibiotic effect via gold:silver-alloy nanoparticles
  172. Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
  173. RNA Quantification with Gold Nanoprobes for Cancer Diagnostics
  174. Noble Metal Nanoparticles for Biosensing Applications
  175. Gold on paper–paper platform for Au-nanoprobe TB detection
  176. RNA Quantification Using Noble Metal Nanoprobes: Simultaneous Identification of Several Different mRNA Targets Using Color Multiplexing and Application to Cancer Diagnostics
  177. Noble Metal Nanoparticles Applications in Cancer
  178. Nanophotonics for Molecular Diagnostics and Therapy Applications
  179. Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection
  180. Real-time monitoring of PCR amplification of proto-oncogene c-MYC using a Ta2O5 electrolyte–insulator–semiconductor sensor
  181. Experimental photophysical characterization of fluorophores in the vicinity of gold nanoparticles
  182. Coupling single base extension to a spectral codification tool for increased throughput screening
  183. Alloy metal nanoparticles for multicolor cancer diagnostics
  184. Portable optoelectronic biosensing platform for identification of mycobacteria from the Mycobacterium tuberculosis complex
  185. Nanoparticles in Molecular Diagnostics
  186. pH Effect on the Photochemistry of 4-Methylcoumarin Phosphate Esters: Caged-Phosphate Case Study
  187. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles
  188. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis
  189. Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex
  190. New insights into the use of magnetic force microscopy to discriminate between magnetic and nonmagnetic nanoparticles
  191. Use of cyclodextrins as scavengers of inhibitory photo-products in light controlled in vitro synthesis of RNA
  192. Gold–silver-alloy nanoprobes for one-pot multiplex DNA detection
  193. Development of a fast and efficient ultrasonic-based strategy for DNA fragmentation
  194. Optimizing Au-nanoprobes for specific sequence discrimination
  195. Inkjet printed and “doctor blade” TiO2 photodetectors for DNA biosensors
  196. RNA quantification using gold nanoprobes - application to cancer diagnostics
  197. Gold nanoprobes assay for identification of mycobacteria from theMycobacterium tuberculosiscomplex
  198. General FRET-based coding for application in multiplexing methods
  199. Cancer Nanotechnology - Prospects for Cancer Diagnostics and Therapy
  200. Multiplexed spectral coding for simultaneous detection of DNA hybridization reactions based on FRET
  201. Light activation of transcription: photocaging of nucleotides for control over RNA polymerization
  202. Characterization of optoelectronic platform using an amorphous/nanocrystalline silicon biosensor for the specific identification of nucleic acid sequences based on gold nanoparticle probes
  203. Identification of unamplified genomic DNA sequences using gold nanoparticle probes and a novel thin film photodetector
  204. Gold nanoparticles for the development of clinical diagnosis methods
  205. Imaging Gold Nanoparticles for DNA Sequence Recognition in Biomedical Applications
  206. Gold Nanoparticle Based Systems in Genetics
  207. Amorphous/nanocrystalline silicon biosensor for the specific identification of unamplified nucleic acid sequences using gold nanoparticle probes
  208. Novel Optoelectronic Platform using an Amorphous/Nanocrystalline Silicon Biosensor for the Specific Identification of Unamplified Nucleic Acid Sequences Based on Gold Nanoparticle Probes
  209. Nanodiagnostics: fast colorimetric method for single nucleotide polymorphism/mutation detection
  210. Gold-Nanoparticle-Probe–Based Assay for Rapid and Direct Detection of Mycobacterium tuberculosis DNA in Clinical Samples
  211. Colorimetric detection of eukaryotic gene expression with DNA-derivatized gold nanoparticles
  212. Principles in genetic risk assessment
  213. Construction and Analysis of a Sequence-Ready Map in 4q25: Rieger Syndrome Can Be Caused by Haploinsufficiency ofRIEG, but Also by Chromosome Breaks ≈90 kb Upstream of This Gene